Cytek Biosciences, Inc.CTKBNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank67
3Y CAGR+1.5%
5Y CAGR+21.6%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+1.5%/yr
Annual compound
5Y CAGR
+21.6%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$36.47M-7.4%
2024$39.40M-10.8%
2023$44.15M+26.7%
2022$34.86M+42.6%
2021$24.44M+78.5%
2020$13.69M+53.3%
2019$8.93M-